RY

164.44

+0.61%↑

TD

95.86

+0.66%↑

BMO

137.35

+0.76%↑

CM

97.17

+0.98%↑

BNS

70.28

+0.21%↑

RY

164.44

+0.61%↑

TD

95.86

+0.66%↑

BMO

137.35

+0.76%↑

CM

97.17

+0.98%↑

BNS

70.28

+0.21%↑

RY

164.44

+0.61%↑

TD

95.86

+0.66%↑

BMO

137.35

+0.76%↑

CM

97.17

+0.98%↑

BNS

70.28

+0.21%↑

RY

164.44

+0.61%↑

TD

95.86

+0.66%↑

BMO

137.35

+0.76%↑

CM

97.17

+0.98%↑

BNS

70.28

+0.21%↑

RY

164.44

+0.61%↑

TD

95.86

+0.66%↑

BMO

137.35

+0.76%↑

CM

97.17

+0.98%↑

BNS

70.28

+0.21%↑

Search

Hercules Capital Inc

Închisă

SectorFinanțe

15.16 2.09

Rezumat

Modificarea prețului

24h

Curent

Minim

14.9

Maxim

15.25

Indicatori cheie

By Trading Economics

Venit

-28M

91M

Vânzări

-12M

158M

P/E

Medie Sector

7.676

55.155

EPS

0.48

Randament dividend

11.52

Marjă de profit

57.578

Angajați

100

EBITDA

-3.5M

116M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+29.19% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

11.52%

4.95%

Următoarele câștiguri

30 apr. 2026

Data viitoare de dividende

19 mai 2026

Următoarea dată ex-dividende

12 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-444M

2.6B

Deschiderea anterioară

13.07

Închiderea anterioară

15.16

Sentimentul știrilor

By Acuity

50%

50%

160 / 440 Clasament în Finance

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Hercules Capital Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

6 apr. 2026, 23:17 UTC

Câștiguri

Samsung Forecasts Record First-Quarter Operating Profit

6 apr. 2026, 23:00 UTC

Acțiuni populare

Stocks to Watch: Health Insurers, Mawson, Owlet

6 apr. 2026, 22:13 UTC

Principalele dinamici ale pieței

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 apr. 2026, 21:46 UTC

Achiziții, Fuziuni, Preluări

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 apr. 2026, 17:09 UTC

Principalele dinamici ale pieței

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 apr. 2026, 16:56 UTC

Evenimente importante

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 apr. 2026, 14:47 UTC

Principalele dinamici ale pieței

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 apr. 2026, 00:00 UTC

Evenimente importante

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 apr. 2026, 23:58 UTC

Market Talk
Evenimente importante

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 apr. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 apr. 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 apr. 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 apr. 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 apr. 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 apr. 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 apr. 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 apr. 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 apr. 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 apr. 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 apr. 2026, 18:36 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 17:59 UTC

Market Talk
Evenimente importante

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 apr. 2026, 17:13 UTC

Achiziții, Fuziuni, Preluări

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 apr. 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 apr. 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 apr. 2026, 14:59 UTC

Câștiguri

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparație

Modificare preț

Hercules Capital Inc Așteptări

Obiectiv de preț

By TipRanks

29.19% sus

Prognoză pe 12 luni

Medie 19.25 USD  29.19%

Maxim 25 USD

Minim 15 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHercules Capital Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

6 ratings

4

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

17.41 / 17.93Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

160 / 440 Clasament în Finanțe

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Hercules Capital Inc

Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable
help-icon Live chat